• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

MSNBC Floundering Again

Bubble Burster

Guest
Now they are shuffling their prime time schedule, trying to get someone to watch.

I feel rather sorry for them. The most popular programming on their propaganda network is the one about convicted murderers in prison.